Simplify Propel Opportunities ETF Rating $17.94 -0.21 (-1.16%) As of 07/24/2026 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsBuy This Stock Simplify Propel Opportunities ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.SURI Aggregate RatingModerate Buy 2.59Holdings in SURI have an aggregate rating of Moderate Buy based on 181 analyst ratings issued in the past year covering 21 companies (92.3% of the portfolio).SURI Aggregate Price Target$17.94High Prediction$17.94Average Prediction$17.94Low Prediction$17.94Holdings in SURI have an aggregate price target of $17.94 and a range of $17.94 to $17.94 covering 21 companies (92.3% of the portfolio).SURI Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy6 Buy rating(s)Moderate Buy13 Moderate Buy rating(s)Hold2 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Simplify Propel Opportunities ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 21 SURI Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings42.98%PAGPPlains GP$26.45-0.2%2.4066 of 5 stars2.31$23.36 -11.7%13News CoverageDividend AnnouncementAnalyst Upgrade11.65%ACHVAchieve Life Sciences$6.10-1.1%2.5627 of 5 stars3.00$16.00 162.3%7News Coverage5.14%MISTMilestone Pharmaceuticals$1.16-3.3%2.2434 of 5 stars2.67$7.25 525.0%6Positive News4.22%DCTHDelcath Systems$12.22-1.7%2.7017 of 5 stars2.57$22.17 81.4%7News Coverage3.76%PHATPhathom Pharmaceuticals$11.44-1.4%2.2524 of 5 stars2.86$24.50 114.2%7News CoverageUpcoming Earnings3.10%CORTCorcept Therapeutics$95.36-1.3%2.2498 of 5 stars2.75$88.83 -6.8%8News CoverageUpcoming Earnings2.38%CLDXCelldex Therapeutics$35.28-0.4%2.3142 of 5 stars2.86$52.77 49.6%14News CoverageAnalyst Forecast2.29%ABEOAbeona Therapeutics$6.05-5.2%3.5675 of 5 stars2.67$19.00 214.0%3Positive News1.97%CASHPathward Financial$85.90+3.3%4.191 of 5 stars3.00$101.00 17.6%3Trending NewsEarnings ReportAnalyst Forecast1.83%IVAInventiva$4.46-1.1%2.3468 of 5 stars3.09$16.56 271.2%111.76%CMPSCompass Pathways$11.26-3.8%3.1119 of 5 stars2.94$24.15 114.5%16News CoverageUpcoming Earnings1.74%KYTXKyverna Therapeutics$7.41+1.6%2.6499 of 5 stars2.67$30.00 304.9%6Positive News1.45%LONAAthira Pharma$7.39+2.1%3.5554 of 5 stars2.40$15.00 103.0%5Positive NewsGap Up1.42%AQSTAquestive Therapeutics$3.68-2.4%2.3107 of 5 stars3.00$8.50 131.0%7News CoveragePositive NewsGap Up1.31%ARTVArtiva Biotherapeutics$10.03-1.0%3.7549 of 5 stars2.83$39.00 288.8%6Analyst ForecastGap Up1.06%PALIPalisade Bio$1.95-3.5%2.9596 of 5 stars3.00$9.00 361.5%10News CoveragePositive NewsAnalyst Forecast1.05%ZVRAZevra Therapeutics$9.52-24.0%4.2172 of 5 stars2.82$29.29 207.6%11News CoverageGap DownHigh Trading Volume1.03%OBIOOrchestra BioMed$3.74+2.7%4.1453 of 5 stars2.57$13.60 263.6%7Positive News0.90%OCULOcular Therapeutix$8.51-1.3%2.4425 of 5 stars2.71$25.11 195.1%140.63%EYPTEyepoint Pharmaceuticals$12.19-2.2%2.7226 of 5 stars2.89$43.75 258.9%9News Coverage0.60%IMUXImmunic$13.39-6.2%3.8668 of 5 stars3.00$47.57 255.3%11Positive News This page (NYSEARCA:SURI) was last updated on 7/25/2026 by MarketBeat.com Staff. From Our PartnersLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredBofA: Digital Dollar Coming 2025-2030Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredElon's new "super startup"Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...Banyan Hill Publishing | SponsoredWhere to Put $100 Before Trump's New Tech Law Rolls OutThe Financial Times says a new tech law puts America 'on the verge of a financial revolution.' Yahoo Finance e...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Simplify Propel Opportunities ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Simplify Propel Opportunities ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
